Crossmark Global Holdings’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $32.6M | Buy |
129,445
+49,645
| +62% | +$10.7M | 0.42% | 46 |
|
|
2026
Q1 | $17.4M | Buy |
79,800
+16,686
| +26% | +$3.7M | 0.26% | 90 |
|
|
2025
Q4 | $14.4M | Sell |
63,114
-1,818
| -3% | -$414K | 0.21% | 111 |
|
|
2025
Q3 | $15M | Buy |
64,932
+19,340
| +42% | +$3.94M | 0.23% | 106 |
|
|
2025
Q2 | $8.46M | Sell |
45,592
-717
| -2% | -$133K | 0.14% | 182 |
|
|
2025
Q1 | $9.7M | Sell |
46,309
-31,083
| -40% | -$6.04M | 0.17% | 148 |
|
|
2024
Q4 | $13.8M | Sell |
77,392
-3,435
| -4% | -$632K | 0.25% | 92 |
|
|
2024
Q3 | $16M | Buy |
80,827
+1,045
| +1% | +$195K | 0.28% | 85 |
|
|
2024
Q2 | $13.7M | Sell |
79,782
-4,199
| -5% | -$696K | 0.26% | 88 |
|
|
2024
Q1 | $15.3M | Sell |
83,981
-11,161
| -12% | -$1.92M | 0.29% | 78 |
|
|
2023
Q4 | $14.7M | Buy |
95,142
+1,738
| +2% | +$253K | 0.31% | 75 |
|
|
2023
Q3 | $13.9M | Buy |
93,404
+588
| +0.6% | +$86.3K | 0.32% | 74 |
|
|
2023
Q2 | $14M | Buy |
92,816
+3,934
| +4% | +$577K | 0.3% | 77 |
|
|
2023
Q1 | $14.2M | Sell |
88,882
-84,689
| -49% | -$12.9M | 0.33% | 67 |
|
|
2022
Q4 | $28.1M | Sell |
173,571
-12,693
| -7% | -$1.95M | 0.7% | 17 |
|
|
2022
Q3 | $25M | Buy |
186,264
+599
| +0.3% | +$86K | 0.69% | 19 |
|
|
2022
Q2 | $28.4M | Buy |
185,665
+61,058
| +49% | +$9.33M | 0.74% | 16 |
|
|
2022
Q1 | $20.2M | Buy |
124,607
+481
| +0.4% | +$69.9K | 0.45% | 39 |
|
|
2021
Q4 | $16.8M | Buy |
124,126
+8,656
| +7% | +$1.02M | 0.37% | 58 |
|
|
2021
Q3 | $12.5M | Buy |
115,470
+1,953
| +2% | +$223K | 0.29% | 84 |
|
|
2021
Q2 | $12.8M | Sell |
113,517
-86,390
| -43% | -$9.73M | 0.3% | 80 |
|
|
2021
Q1 | $21.6M | Sell |
199,907
-3,432
| -2% | -$367K | 0.54% | 31 |
|
|
2020
Q4 | $21.8M | Sell |
203,339
-2,359
| -1% | -$227K | 0.55% | 30 |
|
|
2020
Q3 | $18M | Buy |
205,698
+66,801
| +48% | +$6.29M | 0.51% | 32 |
|
|
2020
Q2 | $13.6M | Buy |
138,897
+21,747
| +19% | +$1.91M | 0.4% | 47 |
|
|
2020
Q1 | $8.93M | Sell |
117,150
-75,438
| -39% | -$6.43M | 0.32% | 86 |
|
|
2019
Q4 | $17.1M | Sell |
192,588
-774
| -0.4% | -$64.3K | 0.47% | 39 |
|
|
2019
Q3 | $14.6M | Sell |
193,362
-7,089
| -4% | -$486K | 0.43% | 50 |
|
|
2019
Q2 | $14.6M | Sell |
200,451
-5,871
| -3% | -$461K | 0.41% | 48 |
|
|
2019
Q1 | $16.6M | Sell |
206,322
-1,499
| -0.7% | -$123K | 0.47% | 38 |
|
|
2018
Q4 | $19.2M | Sell |
207,821
-5,943
| -3% | -$523K | 0.59% | 28 |
|
|
2018
Q3 | $20.2M | Sell |
213,764
-266
| -0.1% | -$25.2K | 0.51% | 35 |
|
|
2018
Q2 | $19.8M | Sell |
214,030
-6,299
| -3% | -$615K | 0.53% | 27 |
|
|
2018
Q1 | $20.9M | Sell |
220,329
-3,833
| -2% | -$421K | 0.54% | 28 |
|
|
2017
Q4 | $21.7M | Buy |
224,162
+11,994
| +6% | +$1.13M | 0.52% | 29 |
|
|
2017
Q3 | $18.9M | Buy |
+212,168
| New | +$16.2M | 0.49% | 35 |
|
|
2016
Q3 | $18.9M | Buy |
+212,168
| New | +$13.7M | 0.49% | 35 |
|
Other funds holding ABBV
Crossmark Global Holdings's ABBV Position: Q2 2026 in Review
Crossmark Global Holdings increased its AbbVie (ABBV) stake by 62% in Q2 2026, buying an estimated $10.7M and bringing the position to 129,445 shares worth $32.6M. The position accounts for 0.42% of the portfolio, ranked #46.
Crossmark Global Holdings first reported a position in ABBV in Q3 2016 and has held it in 37 quarters since. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Crossmark Global Holdings held 129,445 shares of AbbVie worth $32.6M as of Q2 2026.
- Crossmark Global Holdings bought 49,645 AbbVie shares in Q2 2026, an estimated $10.7M.
- AbbVie made up 0.42% of Crossmark Global Holdings's portfolio in Q2 2026, its #46 holding.
- Crossmark Global Holdings first reported a position in AbbVie in Q3 2016 and has held it in 37 quarters since.
- 4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.